Daxor Corporation (DXR)
DXR Stock Price Chart
Explore Daxor Corporation interactive price chart. Choose custom timeframes to analyze DXR price movements and trends.
DXR Company Profile
Discover essential business fundamentals and corporate details for Daxor Corporation (DXR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
25 Jul 1983
Employees
37.00
Website
https://www.daxor.comCEO
Michael Richard Feldschuh
Description
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
DXR Financial Timeline
Browse a chronological timeline of Daxor Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Aug 2026
EPS estimate is -$0.03, while revenue estimate is $2.80m.
Upcoming earnings on 20 Aug 2026
EPS estimate is -$0.11, while revenue estimate is $1.90m.
Earnings released on 6 Mar 2025
Earnings released on 29 Jun 2024
EPS came in at -$0.34 , while revenue for the quarter reached $71.76k .
Earnings released on 25 Mar 2024
EPS came in at $0.72 , while revenue for the quarter reached $82.45k .
Earnings released on 28 Aug 2023
EPS came in at -$0.32 , while revenue for the quarter reached $80.97k .
Earnings released on 1 Mar 2023
EPS came in at $0.82 , while revenue for the quarter reached $96.40k , missing expectations by -99.76%.
Earnings released on 25 Aug 2022
EPS came in at -$0.22 , while revenue for the quarter reached $135.24k , missing expectations by -98.26%.
Earnings released on 15 May 2022
EPS came in at $0.78 , while revenue for the quarter reached $152.44k .
Earnings released on 15 Nov 2021
EPS came in at -$0.19 , while revenue for the quarter reached $125.65k .
DXR Stock Performance
Access detailed DXR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
